3000+ Attendees, 450 Speakers, 12 Conference Tracks, 100+ Posters
 
MMTC15_Header  
MMTC M Header 

Cambridge Healthtech Institute’s Inaugural

Clinical Cancer Immunotherapy

Translating Cancer Therapy from Promise to Reality

February 19-20, 2015 | The InterContinental San Francisco | San Francisco, CA

 

There is a great need for more effective and less toxic therapies for metastatic cancer patients. Advances in genetically engineered T cells is demonstrating clinical efficacy, eliminating many side effects from traditional chemo and radiation therapies. Cambridge Healthtech Institute's Inaugural Cancer Immunotherapy symposium will demonstrate bench to bedside translation of combination immunotherapies, adoptive T cell therapies, as well as molecular targeted therapies. Case studies using prognostic biomarkers to predict immunotherapy response will also be showcased. The human immune system is inherently capable of recognizing and destroying cancer cells. At this event, attendees will learn more about the translational advances are converting the promise of immunotherapy into reality for cancer treatment.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as T Cell Engineering, Gene and Cell Therapy, Cellular Biology, Immunology, Immunotherapy, Oncology, and Pathology.

Topics will include, but are not limited to: 

  • Predictive/prognostic biomarkers for immunotherapy
    o Serum proteins
    o Circulating DNA
    o Receptor expression
    o Cellular infiltrates
    o Humoral & cellular immune responses
    o Immune system polymorphisms
  • Advances in cancer biology with relevance to anti-tumor immunity
  • Combination immunotherapies
  • Molecularly targeted therapies
  • Adoptive T cell therapy and transfer
  • Dendritic cells
  • Innate/adaptive immune interplay
  • Immune cell trafficking to the tumor microenvironment
  • Immune modulation
  • Checkpoint blockade

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is July 18, 2014. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Samantha Lewis
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: slewis@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

 



Premier Sponsors:

Leica Biosystems 
 

 NanoString2   

 

Singulex 

 

Jackson Laboratory - small logo